3.19 USD
▲+0.02+0.63%
2026-08-03
市值
$7.34M
市盈率
—
EPS
-5.97
股息率
—
52 周区间
2.56 – 14.06
成交量
32.52K
Beta
0.02
目标价
7.50
52W 低 2.5652W 高 14.06
价格走势
公司简介
Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction in Israel. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis. It develops Namodenoson that is in Phase III clinical trial for the treatment of liver cancer; and Phase IIa for the treatment of pancreatic cancer; as well as in Phase IIb trial for the treat...